Implementation of The Future of Drug Discovery: QuantumBased Machine Learning Simulation (QMLS)

Aug 3, 2026

Upload by Anda

Drug development R&D is widely recognized as lengthy and expensive. This paper introduces QMLS to compress the end-to-end discovery cycle into about three to six months while substantially reducing overall cost to roughly 50,000–80,000 USD. For hit generation, MLMG proposes candidate hits from target protein structure and QS filters them by reaction and binding effectiveness. Lead optimization merges and expands overlapping candidates via MLMV, then applies repeated QS screening under safety and reaction standards to yield pre-clinical-ready drugs.

LanguageEnglish

CategoryResearch & Report

FormatPDF

Pages13

Reading Time33 min

AccessFree to download

Introduction

QMLS’s Potential in The Drug R&D Industry

Recap of Previous Study

Detailed Implementation of QMLS

Machine Learning Molecule Generation (MLMG) & Machine Learning Molecule Vari

ISSN: 2321-8363 Impact Factor: 6.308 (An Open Accessible, Fully Refereed and Peer Reviewed Journal) Implementation of The Future of Drug Discovery: QuantumBased Machine Learning Simulation (QMLS) Yew Kee Wong1, Yifan Zhou2*, Yan Shing Liang3, Haichuan Qiu4, Yu Xi Wu5, Bin He6 Basis International School Guangzhou, Guangzhou, China E-mail: [yifan.zhou11882-bigz@basischina.com](yifan.zhou11882-bigz@basischina.com) Received date: 21 May 2023, Manuscript No. ijcsma-23-99419; Editor assigned: 23 May 2023, Pre QC No ijcsma-23-99419 (PQ); Reviewed: 01 June 2023, QC No. ijcsma-23-99419 (Q); Revised: 06 June 2023, Manuscript No. ijcsma-23-99419 (R); Published date: 11 June 2023 doi. 10.5281/zenodo.7983561 Abstract The Research & Development (R&D) phase of drug development is a lengthy and costly process. To revolutionize this process, we introduce our new concept QMLS to shorten the whole R&D phase to three to six months and decrease the cost to merely fifty to eighty thousand USD. For Hit Generation, Machine Learning Molecule Generation (MLMG) generates possible hits according to the molecular structure of the target protein while the Quantum Simulation (QS) filters molecules from the primary essay based on the reaction and binding effectiveness with the target protein. Then, For Lead Optimization, the resultant molecules generated and filtered from MLMG and QS are compared, and molecules that appear as a result of both processes will be made into dozens of molecular variations through Machine Learning Molecule Variation (MLMV), while others will only be made into a few variations. Lastly, all optimized molecules would undergo multiple rounds of QS filtering with a high standard for reaction effectiveness and safety, creating a few dozen pre-clinical-trail-ready drugs. This paper is based on our first ISSN: 2321-8363 Impact Factor: 6.308 (An Open Accessible, Fully Refereed and Peer Reviewed Journal) paper, where we pitched the concept of machine learning combined with quantum simulations. In this paper we will go over the detailed design and framework of QMLS, including MLMG, MLMV, and QS. Keywords: Machine Learning; Quantum Computing; Drug Discovery; Molecule Generation; Molecular Simulation. 1. Introduction 1.1 QMLS’s Potential in The Drug R&D Industry The drug development process is a long and costly endeavor, often taking several years and billions of dollars to bring a new drug to market. One promising approach to streamlining this process is the use of Quantum-Based Machine Learning Simulation (QMLS) . QMLS utilizes the power of quantum computing and machine learning algorithms to simulate and predict the behavior of complex molecular systems, allowing for more efficient and accurate drug discovery. According to a study by Patel et al. (2019), "QMLS has the potential to significantly reduce the time and cost associated with drug discovery, while also increasing the success rate of new drug candidates"[1] . Another study by Wang et al. (2018) found that QMLS can "predict the binding affinity of potential drug candidates with high accuracy, reducing the need for costly and time-consuming experimental testing"[2] . A third study by Liet al. (2017) also highlighted the potential of QMLS in "identifying new drug targets and predicting the effects of drug-target interactions"[3] . Overall, QMLS has the potential to revolutionize the drug development industry by providing a more efficient and effective way to discover new drugs. 1.2 Recap of Previous Study The paper presents a concept of using Quantum-based Machine Learning network (QML) and Quantum Computing Simulation (QS) to revolutionize the Research & Development (R&D) phase of drug development. The proposed method aims to shorten the R&D phase to three to six months and decrease the cost to a fraction of traditional methods. The program takes inputs ofthe target protein/gene structure and primary essay and applies QML network to generate p

FAQs

What is QMLS and what problem does it address in drug discovery?

QMLS is a quantum-based machine learning simulation approach designed to streamline drug development by shortening the R&D timeline and reducing cost compared with traditional workflows.

How does QMLS perform hit generation?

MLMG generates possible hit candidates using the target protein’s molecular structure, and QS filters those candidates based on reaction and binding effectiveness with the target protein.

How are lead candidates optimized and finalized in QMLS?

MLMG and QS results are compared, overlapping candidates are expanded into many molecular variations via MLMV, and then multiple QS rounds filter the optimized molecules using stringent reaction effectiveness and safety criteria for pre-clinical readiness.

Aug 3, 2026

Upload by Anda